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Few data exist regarding the long-term sequelae of acute
renal failure (ARF), and these studies are limited to a few
renal conditions. We aim to assess the 3–5-year survival and
incidence of renal injury in children who previously
developed ARF of varying causes. We queried parents,
physicians, and hospital/state vital statistics records to find
patient survival in 174 children who previously had ARF and
survived to hospital discharge. We assessed the following in
29 children for residual renal injury: (a) microalbuminuria, (b)
glomerular filtration rate (GFR) by Schwartz formula, (c)
hypertension, and (d) hematuria. The 3–5-year survival of
children with ARF who survived to hospital discharge was
139/174 (79.9%). Most deaths (24/35 (68.5%)) occurred
within 12 months after initial hospitalization. Combining
those who died during initial hospitalization and in
subsequent 3–5 years, the overall survival rate was 139/245
(56.8%). In all, 16 children progressed to end-stage renal
disease; thus, renal survival was 127/173 (91%). Those with
primary renal/urologic conditions had lower renal survival
than others (24/35 (68.6%) vs 134/139 (96.4%); Po0.0001).
Among the 29 patients assessed for long-term sequelae at
3–5 years, 17/29 (59%) subjects had at least one sign of renal
injury; microalbuminuria (n¼ 9), hyperfiltration (n¼ 9),
decreased GFR (n¼ 4), and hypertension (n¼ 6). A pediatric
nephrologist was involved in care of only 6/17 (35%) with
chronic renal injury. Patients have high risks of ongoing
residual renal injury and death after ARF; therefore, periodic
evaluation after the initial insult is necessary.
Kidney International (2006) 69, 184–189. doi:10.1038/sj.ki.5000032
KEYWORDS: acute renal failure; renal survival; long-term survival; chronic
renal injury; microalbuminemia; hypertension
Acute renal failure (ARF) is defined as the abrupt inability of the
kidneys to eliminate waste products and regulate electrolyte/
water metabolism. Patients who suffer an ARF episode may
have subsequent renal dysfunction after the original injury, and
children may be more susceptible to this injury due to the
ongoing growth of the kidney during childhood. Some data that
describe long-term renal sequelae in children who had ARF due
to congenital heart diseases,1 Henoch–Schonlein purpura,2 very
low birth weight neonates,3 and hemolytic uremic syndrome
exist.4 Persistent microalbuminuria is common in women 3–5
years after a pre-eclampsia episode.5 Studies in adults6 have
found ongoing renal injury after ARF of multiple etiologies, but
these studies may not be extrapolated to children, since adults
demonstrate higher rates of comorbid illnesses than children.
In the 1980s, intrinsic renal disease and burns comprised the
most common pediatric ARF etiologies.7–13 A recent study
performed in our institution between January 1998 and
December 2001 found that the epidemiology of pediatric
patients with the diagnosis of ARF has broadened over the last
decade.14 Now, pediatric ARF most often results from
complications of other systemic diseases resulting from the
advancements in congenital heart surgery, neonatal care, and
bone marrow and solid organ transplantation. That study
showed that 174/245 (71%) patients survived the initial
hospitalization. At hospital discharge, 68% of survivors
recovered complete renal function, 13% had improved renal
function, 12% sustained renal failure, and 5% progressed to
end-stage renal disease (ESRD). Determining the natural history
following an ARF episode will help clinicians design appropriate
monitoring programs. If renal injury is common, therapeutic
interventions to prevent progression of renal injury can be
sought. In order to assess the long-term outcome of children
with a variety of ARF causes, we conducted a follow-up study to
determine patient and renal survival, to look for signs of kidney
injury, and to assess the health-related quality of life of the
original cohort. To our knowledge, this is the first analysis to
describe the long-term outcome of children after ARF.
RESULTS
Epidemiology
Initial hospital survival. The hospital survival after an ARF
episode at Texas Children’s Hospital between January 1998
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and June 2001 was 174/245 (71%). Patients who required
renal replacement therapy (RRT), intensive care unit (ICU)
admission, and those without primary renal/urologic condi-
tions were less likely to survive hospitalization (Table 1; data
from Hui-Stickle et al.14).
Survival at 3–5 years of initial hospital survivors. The 3–5-
year survival rate for the children with ARF who survived to
hospital discharge was 139/174 (79.9%). No survival dif-
ference was seen for patients with ICU admission vs without
ICU admission, receiving initial RRT vs not receiving initial
RRT, or renal/urologic vs no renal/urologic comorbidity
(Table 1). Of the 35 deaths that occurred after initial hospital
discharge, 24/35 (68.5%) occurred within 12 months and 31/35
(88.6%) occurred within 24 months after initial hospitalization.
Renal survival. Of the initial hospital survivors, at least 16
children progressed to ESRD (three of these have died); thus,
the renal survival at 3–5 years was 158/174 (90.8%). ESRD
occurred more commonly in patients with primary renal/
urologic conditions vs others (24/35 (68.6%) vs 133/139
(95.7%); Po0.0001). Neither ICU admission nor the initial
need for RRT was predictive of long-term renal survival.
Renal injury
Patient population. In all, 119/245 of the original cohort
were known to have either (a) ESRD or (b) died during or
after hospitalization; thus, 126 children were available for
renal injury assessment. Also, 69 subjects did not respond by
phone or mail and 28 subjects refused to participate. Reasons
for refusal included: ‘too busy’ (n¼ 8), ‘adequate follow-up’
(n¼ 3), ‘too hard’ (n¼ 2), ‘live too far’ (n¼ 1), refused to
give a reason (n¼ 3), and did not show (n¼ 11). We
evaluated 29/126 (23%) of potential subjects for signs of
renal injury and health-related quality of life between
February and July 2004 (Figure 1).
Participants in the study and those who were lost or
refused to participate in the study did not differ with regard
to demographics, length of stay, frequency of ICU hospita-
lization, severity of renal failure, and outcome at the time of
discharge. In all, 6/29 (20.6%) subjects evaluated for follow-
up required RRT and 17/29 (56.3%) were ICU patients
during the initial hospitalization. Those with primary renal/
urological disease were more likely to participate in the study
than those without primary renal comorbidity (10/29
(34.4%) vs 12/97 (12.4%); Po0.01) (Table 2).
Signs of renal injury. Of the 29 patients in our study, 17/29
(59%) had at least one sign of renal injury. One patient had
abnormalities in all four indices and eight had abnormalities
Table 1 | Survival in children after ARF
All Patients No ICU ICU Initial RRT No initial RRT
Ren/Uro
comorbid No Ren/Uro
Hospital survival 174/245 (71.0%) 65/66 (98.5%) 109/179 (60.9%) Po0.001 44/75 (58.7%) 130/170 (76.5%) Po0.01 35/37 (94.6%) 139/208 (66.8%) Po0.001
3–5-year survival of
hospital survivors
139/174 (79.9%) 54/65 (83.0%) 85/109 (78.0%) NS 31/44 (70.5%) 108/130 (83.1%) NS 31/35 (88.6%) 108/139 (77.7%) NS
Renal survival 158/174 (90.8%) 56/65 (86.1%) 102/109 (93.6%) NS 37/44 (84.1%) 121/130 (93.1%) NS 24/35 (68.6%) 134/139 (96.4%) Po0.0001
Ren, renal; RRT, renal replacement therapy; Uro, urology.
71 did not survive
32 died after discharge
Parent or MD report
3 Died
13 Alive
16 ESRD
69 Unable to locate
28 Did not show or
refused
29 Subjects
126 potential subjects
174 survived
245 children with ARF at TCH
January 1998 − June 2001
Figure 1 | 3–5-year outcomes of children who developed ARF at
Texas Children’s Hospital between January 1998 and June 2001.
In total, 29 subjects were further evaluated for signs of chronic renal
injury.
Table 2 | Demographics of potential participants
Came
(n=29)
Did not come
(n=97)
Age at hospital admission 6.475.8 6.476.5 NS
Age at follow-up 9.876.5 12.177.2 NS
Years after event 3.770.9 4.171.1 NS
Ethnicity NS
Caucasian 11 (38%) 35 (36.1%)
Hispanic 10 (34%) 27 (27.9%)
African American 6 (21%) 27 (27.9%)
Asian 0 (0%) 4 (4.1%)
Other 2 (7%) 4 (4.1%)
No. of male patients 13 (44.9%) 57 (58.8%) NS
RRT 6 (20.7%) 20 (20.6%) NS
Hypertensive at the time of ARF 9 (31.0%) 27 (27.8%) NS
Urine output at the time of ARF
(ml/kg/h)
3.073.5 2.672.2 NS
GFR minimum (ml/min/1.73 m2) 25.7719.2 26.1720.4 NS
Length of stay (days) 18.6721.5 12.8733.3 NS
No. of patients with primary
renal/urologic conditions
10 (34.4%) 12 (12.4%) Po0.01
No. of patients requiring ICU stay 17 (58.6%) 64(64.3%) NS
Outcome at discharge (no. of patients) NS
Normal 21 (72.4%) 67 (69.1%)
Improve 6 (20.7%) 18 (18.6%)
CRF 2 (6.8%) 12 (12.3%)
Cause of renal failure (no. of patients) NS
Nephrotoxic 3 (10.3%) 15 (15.5%)
Atn/sepsis/hemorrhage 11 (37.9%) 35 (36.1%)
Cardiac 3 (10.3%) 14 (14.4%)
Oncologic 2 (6.9%) 7 (7.2%)
Hemoglobin/myoblobinuria 1 (3.4%) 3 (3.1%)
Primary renal 4 (13.8%) 9 (9.3%)
Pyelonephritis 0 (0.0%) 3 (3.1%)
Unknown 5 (17.2%) 11 (11.3%)
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in two markers. The proportion of children who had at least
one sign of renal injury was similar between those who had
primary renal/urologic conditions compared to those with-
out renal/urologic conditions (5/10 (50%) vs 11/19 (57.9%);
NS). Only 6/17 (35%) patients who had signs of renal injury
in at least one domain had follow-up with a pediatric
nephrologist at the time of the study (Table 3).
Glomerular filtration rate (GFR). At the time of follow-up,
the average GFR by Schwartz formula was 137.9752.9 ml/min/
1.73 m2 (range 31.1–295.9 ml/min/1.73 m2). We found nine
children with stage 1 chronic kidney disease (hyperfiltration as
defined by Schwartz formula creatinine clearance (CCl)
4150 ml/min/1.73 m2) and four children with chronic kidney
disease stage 2 (CCl by Schwartz formulao90 ml/min/1.73 m2).
Microalbuminuria. The mean spot urine albumin/creati-
nine ratio was 46.2784.7 (range¼ 4.1–402.1). Eight patients
had microalbuminuria (urine albumin/creatinine430).
Microalbuminuria was more common in patients who had
stage 1 chronic kidney disease compared to those with
normal GFR (Po0.02) (Table 4). Of the eight patients with
microalbuminuria, seven had at least one other marker of
renal injury. The one patient who solely had microalbumi-
nuria was a patient with acute lymphocytic leukemia who did
not have primary urologic or renal disease.
Hematuria. Only one patient had microscopic hematuria.
This patient also had hypertension, microalbuminuria, and
chronic renal failure.
Hypertension. Six patients were found to be hypertensive:
four patients had hypertension as defined by the fourth
report on pediatric hypertension by repeat clinic blood
pressure measurement. Although four patients were pre-
scribed antihypertensive medications, only two were for
blood pressure control, one for tachycardia, and one for
after-load reduction.
We found no correlation between hypertension and
microalbuminuria or GFR. Hypertension, urine output,
and degree of renal failure (nadir GFR) during initial
hospitalization were not predictive of hypertension, micro-
albuminuria, and abnormalities in GFR at the time of follow-
up in our cohort of patients.
Of the patients who required RRT during the initial
episode of ARF, 4/6 children had signs of renal injury at the
time of follow-up (two had hyperfiltration and four had
hyperfiltration and microalbuminuria).
Quality of life
By performing PedsQLTM 4.0, we found no difference between
children with ARF compared to healthy population.
Table 3 | Signs of renal injury 3–5 years after ARF episode
Subject no. Overall BP
GFR at follow-up
(ml/min/1.73 m2) GFR outcome
Spot urine
Alb/Cr Microalbumin Hematuria
Follow-up
by renal
No.
abnormal
1 H* 118.4 N 402.1 Yes No Yes 2
2 N 109.0 N 59.5 Yes No No 1
3 N 177.5 H 22.8 No No Yes 1
4 N 166.3 H 52.3 Yes No No 2
5 H 182.0 H 6.3 No No No 2
7 N 199.0 H 96.6 Yes No Yes 2
11 H* 31.1 L 256.6 Yes Yes Yes 4
13 N 86.2 L 25.5 No No No 1
14 N 219.3 H 53.2 Yes No No 2
16 H 66.7 L 11.9 No No Yes 2
18 N 295.9 H 48.7 Yes No No 2
19 H 111.6 N 7.5 No No No 1
21 N 49.2 L 98.9 Yes No No 2
23 H 117.4 N 23.9 No No Yes 1
26 N 187.2 H 18.4 No No No 1
28 N 169.1 H 10.8 No No No 1
29 N 185.5 H 10.2 No No No 1
Total=17 HTN=6 CRF stage 1=9
CRF stage 2=4
Microalbumin=8 Hematuria=1 Renal F/U=6
Two patients (*) on antihypertensives for BP control.
CRF stage 1: ClCr X150 mg/min/1.73 m2.
CRF stage 2: ClCr o90 mg/min/1.73 m2.
Microalbuminuria: spot urine alb/cr X30.
H, high; HTN, hypertension; L, low; N, normal.
Table 4 | GFR vs microalbuminuria
CRF
(CClo90 ml/min/1.73 m2)
Normal
(90oCCl 4150 ml/min/1.73 m2)
Hyperfiltration
(CCl4150 ml/min/1.73 m2) Total
Normal urine albumin/creatinine 2 14 5 21
Microalbuminuria urine Alb/Cr430 2 2 4* 8
Total 4 16 9 29
*P=0.02 vs. normal.
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DISCUSSION
To our knowledge, this is the first analysis that evaluates the
longitudinal epidemiology of children who have survived an
ARF episode irrespective of cause. We found that children
with ARF who survived hospitalization have a high risk of
death, as only 139/174 (79.9%) were alive 3–5 years after the
initial incident. When combining those who died during
initial hospitalization and those who died subsequently, the
survival rate is 139/245 (56.8%), and thus a high proportion
(106/245 (43.2%)) of children who sustain ARF are deceased
3–5 years following initial incident.
Estimates for renal survival are limited as we only queried
the Texas Children’s hospital ESRD databases, and patients
who may have progressed to ESRD at other programs were
not included in our analysis. Although only a small
proportion of patients had primary renal conditions as the
cause of ARF, this group had the lowest renal survival (24/35
(68.6%)). At 3–5 years after the initial ARF episode, only (5/
139 (3.6%)) survivors without primary renal conditions
progress to ESRD.
To evaluate renal injury, we used four concrete measures
(microalbuminuria, hyperfiltration or decreased GFR, hema-
turia, and hypertension) as markers of renal injury Although
only 29/125 potential subjects were evaluated for renal injury,
the addition of 32 patients who died after hospitalization and
16 who progressed to ESRD represents 77/173 (44.5%) of all
hospital survivors. We found that 17/29 (59%) of patients
had at least one abnormality at follow-up visit. We included
hyperfiltration (chronic kidney disease stage 1) because
experimental studies have incriminated glomerular hyperfil-
tration in mediating progressive renal damage from various
initiating injuries.15 However, the Schwartz formula for
hyperfiltration can overestimate GFR in small children and is
not the most sensitive way to evaluate hyperfiltration in older
children. Nonetheless, only four patients had hyperfiltration
as the sole marker of renal injury.
As noted in Table 4, children who have hyperfiltration are
more likely to have microalbuminuria and only two patients
who had normal renal function were found to have
microalbuminuria. Microalbuminuria is considered a marker
of vascular endothelium dysfunction. In adults, urinary
albumin/creatinine ratios as low as 6.7 mg/g have been
associated with all-cause morality in subjects who otherwise
appeared healthy.16 We were unable to perform first-morning
urine collections due to research design; so we cannot
discount that some patients may have had orthostatic
proteinuria. Despite this limitation, only one patient had
solely microalbuminuria as a sign of renal injury. Whether
microalbuminuria is a reliable marker for renal injury by
itself in this population is yet to be determined.
Although this study encompasses a small proportion of all
survivors in a single center, we found a high rate of residual
or ongoing renal injury in those with primary renal/urologic
diseases, as well as those with other causes of renal injury,
such as ischemia and nephrotoxic medication injury.
Previous studies have shown that specific ARF causes, such
as hemolytic–uremic syndrome, can lead to hypertension,
microalbuminuria, and chronic renal failure. Our study
showed that children with a wide range of causes of ARF have
a significant risk for chronic renal injury, ESRD, and
mortality irrespective of ARF cause.
In light of the high incidence of chronic renal injury after
ARF that we observed, we suggest that children should be
screened regularly for signs of renal disease after an ARF
episode. Of the 17/29 (59%) children who had signs of renal
injury, only 6/17 (35%) had follow-up with a pediatric
nephrologist. Four of these children, two with chronic renal
insufficiency and two with hypertension, have conditions that
require prompt interventions to optimize growth and prevent
further end-organ injury. Although the others had signs of
renal injury that would not need immediate attention, long-
term follow-up to intervene early is vital, as injury
progression is likely to occur. Furthermore, adult studies
have found that even minor renal disease is an independent
predictor of cardiovascular disease and mortality,17–19 and
therapeutic interventions can slow progression and reverse
renal injuries.20 Early intervention for the pediatric patient
with minor renal dysfunction may provide a significant
impact on long-term cardiovascular health.
Unfortunately, the retrospective design of this study did
not allow further analysis into the causes of deaths, the
impact of primary and comorbid illness on mortality, nor
assess the impact that ARF per se had on outcome in these
children who were already at risk for death. Clearly,
prospective trials will be needed to answer these questions,
further define the pathophysiologic mechanisms of disease,
and search for therapeutic interventions to limit renal injury
and improve outcomes.
Conclusions
After an ARF episode, children have a high incidence of death
and long-term renal injury. As the risk for long-term renal
injury is high, children should be evaluated periodically for
signs of renal injury for years after the initial insult.
Prospective longitudinal multi-center studies are needed to
further define this population, define the etiology of
sustained renal injury, and evaluate strategies to slow or
prevent progressive renal injury in the wake of ARF.
MATERIALS AND METHODS
Epidemiology
This cross-sectional cohort study analyzes the 3–5-year survival
outcomes of the 174 children with ARF who survived hospitalization
at Texas Children’s Hospital between January 1998 and June 2001.
Patients were selected if they had a diagnosis of ARF on either the
discharge or death summary. Patients were then screened for
estimated corrected GFR and only those patients with a GFR
p75 ml/min/1.73 m2 were selected for further analysis. The decision
to start RRT was made by the renal physician on call.
Children with chronic renal disease or previous transplant kidney
prior to the ARF episode were excluded from the study. The
Institutional Review Board of Baylor College of Medicine approved
this human study.
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Physicians from the Texas Children’s Hospital Renal, Cardiology,
Hepatology and Bone Marrow Transplant sections were provided a
list of survivors from the original cohort in their field to assess
survival. In addition, the medical records departments at Texas
Children’s Hospital and the Texas Department of Health’s Vital
Statistics office were queried. To assess renal survival, we queried the
Texas Children’s Hospital dialysis and transplantation database.
Subgroup analysis was performed to compare for those with primary
renal/urologic disease vs others, those who initially required RRT vs
none, and those who were admitted to ICU vs non-ICU patients.
Assessment of renal injury
The families of patients who had not progressed to ESRD were
initially contacted to participate by mail, and those who did not
respond were contacted by telephone. Of the 126 potential
participants in the study, 29 agreed to participate in the study
(Figure 1). After obtaining informed consent, subjects had physio-
logical measurements performed during a single study visit, including
height and weight with associated percentiles; history and physical
examination was performed. We estimated GFR by Schwartz estimate
for creatinine clearance (CCl) and compared this to normative data
(normal CCl¼ 90–150 ml/min/1.73 m2).21 Chronic renal failure was
defined as CClo90 ml/min/1.73 m2; hyperfiltration was defined as
CCl4150 ml/min/1.73 m2. Serum creatinine was performed with
Vitros E-950TM (Ortho/Clinical Diagnostics; Rochester, NY).
A clean-catch urine specimen was collected from the subjects.
Due to experimental design, a first morning void was not performed
for most children. Urine albumin/creatinine ratio was calculated
using the Bayers DCA 2000 analyzer (Elkhart, IN). Measurement of
microalbuminuria by this method is a valid surrogate for 24-h
microalbumin collection as spot urine albumin/creatinine ratio
correlates well with 24-h collection for albumin.22 Microalbuminur-
ia greater than 30 mg/24 h is construed as a reliable marker for renal
injury;22–24 thus, spot urine albumin/creatinine ratio X30 was
defined as microalbuminuria. Evaluation of urine albumin/creati-
nine ratio showed that healthy children have between 7 and 12%
chance to have ratios above 30 on random samples and a 2.6%
chance on first-morning urine collections.25–27 Hematuria was
analyzed with Multistix 10SG reagent strips for urinalysis (Bayers
2161; Strawberry Hill, UK).
Assessment of systolic blood pressure and diastolic blood
pressure was determined by taking the mean of three relaxed,
seated, upper extremity readings with a blood pressure monitor
(Dinamaps) and cuff of an appropriate size. A subject was
considered hypertensive if his/her systolic blood pressure or diastolic
blood pressure was greater than the 95th percentile for sex, height,
and age as described by the Fourth Report on High Blood Pressure
in Children and Adolescents.28 Children on antihypertensive
medications were considered hypertensive in our study only if they
received medications for blood pressure control, and not for
proteinuria, afterload reduction, tachycardia, or other abnormalities.
In order to assess health-related quality of life, we administered
the PedsQLTM 4.0 Generic Scale questionnaire during their clinic visit
in either English or Spanish, depending on primary language. Data
were compared to normative PedsQLTM standards.29–31 Internal
consistency reliability was explored for all age groups.
Statistical analysis
w2 analysis was used to determine renal and patient survival
differences. Demographics of potential participants were analyzed
using Student’s t-test when parametric variables were used. w2
analysis was performed for two categories of nonparametric
variables. Mann–Whitney U-test was performed on nonparametric
measurements that had multiple categories. Fisher’s exact test was
used when evaluating nonparametric renal injury difference out-
comes when the number of subjects in any group was less than 5.
Analysis of PedsQLTM subscale, total score means, and standard
deviation was carried out using analysis of variance. Po0.05 was
considered statistically significant.
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